Men undergoing androgen deprivation therapy for prostate cancer lose significant muscle protein content within 6 weeks of induction of hypogonadism (Lam et al., 2019)
Once the lesion is fully formed, it generally remains stable rather than continuing to enlarge, a feature that helps distinguish it from melanoma, which typically continues to change
Notably, experiments in mice showed that a high-fat diet or clock-disrupting conditions alter microbial rhythms, which then contributes to hepatic circadian clock dysfunction and obesity
Related Topics BPC-157 + TB-500 for Injury Recovery combination protocol for musculoskeletal healing BPC-157 + TB-500 Dosing Calculator BAC water and per-vial draw for the Wolverine Stack GLOW Protocol Guide multi-peptide blend featuring BPC-157 for skin GHK-Cu Guide often combined with BPC-157 for tissue quality NAD+ Guide cellular energy support for recovery Thymosin Alpha-1 Guide immune modulation through Treg expansion TB-500 Guide Standalone Thymosin Beta-4 deep-dive Where to Inject Peptides Compound-level injection guide with BPC-157 body-part breakdown Peptide Reconstitution Guide How to mix and prepare peptide vials Injury Recovery Protocol BPC-157 is core of the 3-tier injury recovery framework References Mechanism Notes Angiogenic signaling BPC-157 activates VEGFR2AkteNOS cascade, upregulates VEGF, promotes endothelial sprout formation and capillary network restoration: PMC8275860 Tight junctions BPC-157 increases expression of ZO-1 and occludin, sealing gaps between epithelial cells in intestinal barrier: PMC6271067 Anti-inflammatory modulation Suppresses TNF-, IL-1, IL-6 without immunosuppression
